Operating Lease, Right-of-Use Asset of ORAMED PHARMACEUTICALS INC. from 01 Sep 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Sep 2019 to 30 Sep 2025.
  • ORAMED PHARMACEUTICALS INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $817,000, a 68% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $817,000 +$331,000 +68% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $882,000 +$316,000 +56% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $342,000 -$266,000 -44% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $414,000 -$280,000 -40% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $486,000 -$282,000 -37% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $566,000 -$276,000 -33% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $608,000 -$307,000 -34% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $694,000 -$293,000 -30% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $768,000 -$237,000 -24% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $842,000 -$234,000 -22% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $915,000 -$193,000 -17% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $987,000 +$487,000 +97% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 $1,005,000 +$472,000 +89% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,076,000 +$516,000 +92% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $1,108,000 +$500,000 +82% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $500,000 -$140,000 -22% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $533,000 +$458,000 +611% 31 Aug 2021 10-QT 30 Mar 2022 2021 Q2
Q2 2021 $560,000 +$471,000 +529% 31 May 2021 10-Q 14 Jul 2021 2021 Q3
Q1 2021 $608,000 +$509,000 +514% 28 Feb 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 $640,000 +$534,000 +504% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 $75,000 -$93,000 -55% 31 Aug 2020 10-K 24 Nov 2021 2021 FY
Q2 2020 $89,000 31 May 2020 10-Q 07 Jul 2020 2020 Q3
Q1 2020 $99,000 29 Feb 2020 10-Q 06 Apr 2020 2020 Q2
Q4 2019 $106,000 30 Nov 2019 10-Q 09 Jan 2020 2020 Q1
Q3 2019 $168,000 01 Sep 2019 10-Q 13 Apr 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.